Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Ubiquitin Signalling Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
Nat Rev Mol Cell Biol. 2019 Jun;20(6):338-352. doi: 10.1038/s41580-019-0099-1.
The deubiquitylating enzymes (DUBs, also known as deubiquitylases or deubiquitinases) maintain the dynamic state of the cellular ubiquitome by releasing conjugated ubiquitin from proteins. In light of the many cellular functions of ubiquitin, DUBs occupy key roles in almost all aspects of cell behaviour. Many DUBs show selectivity for particular ubiquitin linkage types or positions within ubiquitin chains. Others show chain-type promiscuity but can select a distinct palette of protein substrates via specific protein-protein interactions established through binding modules outside of the catalytic domain. The ubiquitin chain cleavage mode or chain linkage specificity has been related directly to biological functions. Examples include regulation of protein degradation and ubiquitin recycling by the proteasome, DNA repair pathways and innate immune signalling. DUB cleavage specificity is also being harnessed for analysis of ubiquitin chain architecture that is assembled on specific proteins. The recent development of highly specific DUB inhibitors heralds their emergence as a new class of therapeutic targets for numerous diseases.
去泛素化酶(DUBs,也称为去泛素化酶或去泛素连接酶)通过从蛋白质上释放连接的泛素来维持细胞泛素组的动态状态。鉴于泛素的许多细胞功能,DUB 在细胞行为的几乎所有方面都占据着关键的角色。许多 DUB 对特定的泛素连接类型或泛素链中的特定位置具有选择性。其他 DUB 表现出链型混杂性,但可以通过结合域外的结合模块建立特定的蛋白质-蛋白质相互作用,从而选择不同的蛋白质底物。泛素链切割模式或链连接特异性与生物学功能直接相关。例如,蛋白酶体对蛋白质降解和泛素回收的调节、DNA 修复途径和先天免疫信号转导。DUB 切割特异性也被用于分析特定蛋白质上组装的泛素链结构。最近高度特异性 DUB 抑制剂的开发预示着它们作为治疗许多疾病的新一类治疗靶点的出现。